当前位置:首页 >> 代理品牌 >> Abnova

台湾Abnova

Abnova
Abnova是世界上最大的单克隆抗体和蛋白生产商之一,现有抗体数量近10000种,其中有2/3是单克隆抗体。另外还通过麦胚体外表达系统制备了近8000种蛋白,其中有3000种为全长蛋白。

Abnova具有每月开发500种小鼠单克隆抗体的能力。Abnova采用的单克隆抗体的生产技术比传统的单克隆抗体制备技术更为先进。其研发的目标是针对每一个人类表达基因开发至少一种抗体。

Abnova is the world's largest antibody manufacturer. We have the capacity of generating 300 mouse monoclonal antibodies and 200 rabbit polyclonal antibodies per month. Rather than the traditional method of antibody production, Abnova is taking a genomic/proteomic approach for the antibody development. Our goal is to have at least one antibody to every human expressed gene in human genome. We manufacture all our products, recombinant proteins and antibodies in our state-of-the-art production and SPF animal facilities. We also have multiple clones for the monoclonal antibody, and their access is available to partners and collaborators from the academic institutions and industry.
 

 
The Gap between Genomics and Proteomics

After the completion of human genomic project, most human expressed genes have been identified, and full-length cDNA of these genes have become publicly available. In the emerging proteomics era, proteins act as the key players in the unveiling of these genes. In order to effectively decipher the mystery of these proteins, antibodies with their inherent sensitivity and specificity thus become the most versatile tools for providing one-to-one relationship with their target proteins.

 
What Abnova Does

The mission of Abnova is to become a leader in high throughput antibody and protein production. Abnova intends to become world's largest protein and antibody catalog company by building a full collection of essential proteins and their antibodies targeting the human genome.

 
Why Choose Abnova?

Abnova offers a unique complete monoclonal antibody and protein experience for our customer that is different from traditional custom production companies and laboratories.
Industrial-Scale Infrastructure: We maintain a streamlined monoclonal production facility with scalable capacity for up to 500 immunization per month, and a state-of-the-art specific pathogen free (SPF) facility, which has the breeding and holding capacity for 10,000+ mice. These facilities allow us to significantly bring down the cost of customized monoclonal antibody production. We have also incorporated numerous automation systems into our production line, which significantly increased our efficiency.
Wheat Germ In Vitro Protein Expression System: We have a high throughput protein production system, which allows soluble expression of conformational correct protein either from full-length cDNA or specific domains.
版权所有 2004-2011 上海博晗生物科技有限公司
欢迎拨打服务热线: 021-54253791,64693763 邮箱: order@biosun.cn
沪ICP备10213400号-1